MEFLOQUINE HYDROCHLORIDE (mefloquine hydrochloride) by Teva is clinical pharmacology pharmacokinetics absorption: the absolute oral bioavailability of mefloquine has not been determined since an intravenous formulation is not available. Approved for mild to moderate acute malaria caused by mefloquine-susceptible strains of p. First approved in 2003.
Drug data last refreshed 21h ago
CLINICAL PHARMACOLOGY Pharmacokinetics Absorption: The absolute oral bioavailability of mefloquine has not been determined since an intravenous formulation is not available. The bioavailability of the tablet formation compared with an oral solution was over 85%. The presence of food significantly…
Worked on MEFLOQUINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.